Kevin Hawkins

Articles by Kevin Hawkins

Quality by Design for analytical methods for use with orally inhaled and nasal drug products

ByAndrew Crumpton,Adrian Parkinson,Holger Memmesheimer,Svetlana Lyapustina,Kevin Hawkins,David Christopher,Sebastian Kaerger,Bruce Wyka,Andy Rignall,Mary Ann Smith

October 1st 2008

Pharmaceutical Technology Europe

The design of accurate and robust analytical methodology is instrumental to developing orally inhaled and nasal drug products (OINDPs) and their appropriate control programmes.

Latest Updated Articles

Quality by Design for analytical methods for use with orally inhaled and nasal drug products
October 1st 2008

Kevin Hawkins

Articles by Kevin Hawkins

Quality by Design for analytical methods for use with orally inhaled and nasal drug products

Latest Updated Articles

Trending on Pharmaceutical Technology

EMA Approved 104 Human Medicines in 2025

GSK Acquires Nuvalent for $10.6 Billion in Lung Cancer Push

Overcoming Fill-Finish Capacity Bottlenecks in Automated Pen Injector Assembly Lines

PharmTech Weekly Roundup—June 12, 2026

GSK's Momelotinib Pursues Rare VEXAS Syndrome Indication